NCT00754832 American Ginseng Treatment for Multiple Sclerosis Related Fatigue Status COMPLETED Phase PHASE2
NCT00753792 Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse Status COMPLETED Phase PHASE4
NCT00752778 Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri Status TERMINATED Phase PHASE4
NCT00751881 An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00744679 A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State Status COMPLETED Phase PHASE4
NCT00735007 12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis. Status COMPLETED Phase PHASE3
NCT00715598 Cognitive Testing for the Pain Quality Assessment Scale (PQAS) Status COMPLETED Phase N/A
NCT00711646 A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. Status COMPLETED Phase PHASE3
NCT00702468 Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00702065 A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment Status COMPLETED Phase N/A
NCT00695084 Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS) Status COMPLETED Phase PHASE1
NCT00688948 Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS) Status TERMINATED Phase PHASE2/PHASE3
NCT00681538 A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) Status COMPLETED Phase PHASE3
NCT00678795 A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00678496 Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis Status COMPLETED Phase NA